Your browser doesn't support javascript.
loading
Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28-Stimulated T Cell IFN-γ and TNF-α Production.
Calianese, David; Kreiss, Tamara; Kasikara, Canan; Davra, Viralkumar; Lahey, Kevin C; Gadiyar, Varsha; Geng, Ke; Singh, Sukhwinder; Honnen, William; Jaijyan, Dabbu Kumar; Reichman, Charles; Siekierka, John; Gennaro, Maria Laura; Kotenko, Sergei V; Ucker, David S; Brekken, Rolf A; Pinter, Abraham; Birge, Raymond B; Choudhary, Alok.
Afiliación
  • Calianese D; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Kreiss T; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Kasikara C; Department of Chemistry and Biochemistry, The Herman and Margaret Sokol Institute for Pharmaceutical Life Sciences, Montclair State University, Montclair, NJ.
  • Davra V; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Lahey KC; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Gadiyar V; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Geng K; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Singh S; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Honnen W; Department of Pathology and Laboratory Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ.
  • Jaijyan DK; Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, NJ.
  • Reichman C; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Siekierka J; Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, NJ.
  • Gennaro ML; Department of Chemistry and Biochemistry, The Herman and Margaret Sokol Institute for Pharmaceutical Life Sciences, Montclair State University, Montclair, NJ.
  • Kotenko SV; Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, NJ.
  • Ucker DS; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School Cancer Center, Rutgers University, Newark, NJ.
  • Brekken RA; Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL.
  • Pinter A; Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, Dallas, TX; and.
  • Birge RB; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Choudhary A; Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, NJ.
J Immunol ; 207(2): 436-448, 2021 07 15.
Article en En | MEDLINE | ID: mdl-34215655
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfatidilserinas / Linfocitos T CD4-Positivos / Interferón gamma / Factor de Necrosis Tumoral alfa / Muromonab-CD3 / Antígenos CD28 / Linfocitos T CD8-positivos / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfatidilserinas / Linfocitos T CD4-Positivos / Interferón gamma / Factor de Necrosis Tumoral alfa / Muromonab-CD3 / Antígenos CD28 / Linfocitos T CD8-positivos / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2021 Tipo del documento: Article